Alniche Lifesciences to Expand into Cardio-Diabetic Area
Introduction of value-added products to take care of vital organs of circulatory system September 2021: Alniche Lifesciences is planning to expand into a new therapy area i.e. cardio-diabetic. This includes the introduction of value-added products to take care of vital organs of the circulatory system that are severely affected due to COVID pandemic. “It’s alarming […]
Continue Reading